Gastroesophageal Reflux Disease (GERD) Device Market Expected to Reach $3.03 Billion by 2030

NEW YORK - June 11, 2025 - PRLog -- The Global Gastroesophageal Reflux Disease (GERD) Device Market is poised for significant expansion, with an estimated market value projected to reach USD 3.03 billion by 2030. This growth, occurring at a compound annual growth rate (CAGR) of approximately 3.24%, is primarily driven by an alarming increase in GERD cases globally. Contributing factors include unhealthy dietary choices, a sedentary lifestyle, and an aging population that is increasingly susceptible to gastrointestinal disorders.

Key Market Insights:

• Market Value (2024): Approximately USD 2.5 billion
• Projected Market Value (2030): USD 3.03 billion
• CAGR (2025-2030): 3.24%

Gastroesophageal Reflux Disease (GERD) Device Market Trend:

Surge in Minimally Invasive and Advanced Diagnostic Technologies – There is a marked trend toward the adoption of minimally invasive GERD treatment devices and advanced diagnostic tools. Innovations such as high-resolution manometry (HRM), wireless pH monitoring systems (e.g., Bravo capsule), and AI-powered endoscopic imaging are streamlining early detection, improving diagnostic accuracy, and enhancing patient comfort. These technologies enable quicker recovery, fewer complications, and more precise interventions, making them increasingly favored by both clinicians and patients.

Download Free PDF Sample - https://www.marknteladvisors.com/query/request-sample/global-gastroesophageal-reflux-disease-device-market.html

Gastroesophageal Reflux Disease Device Market Challenge:

Stringent Regulatory Approvals and Restrictive Reimbursement Policies – One of the most significant challenges restricting the growth of the global gastroesophageal reflux disease (GERD) device market is the presence of stringent regulatory approval processes and restrictive reimbursement policies. These hurdles make it difficult for new devices to enter the market quickly, delay commercialization, and limit patient access to innovative technologies. Regulatory requirements often entail lengthy clinical trials and complex documentation, which increase the time and cost for manufacturers to bring new devices to market.

Gastroesophageal Reflux Disease (GERD) Device Market Segmentation:

By Product Type:

1. Diagnostic Devices
2. Treatment Devices (including Esophagoscopes, Gastroscopes)

- Among all, esophagoscopes & gastroscopes hold a prominent share of the Global Gastroesophageal Reflux Disease Device Market.

By Procedure Type:

• Diagnostic Procedures
• Fundoplication Procedures
• Radiofrequency Thermal Ablation
• Magnetic Sphincter Augmentation

By End User:

• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers

By Device Type:

• MUSE
• LINX Management System
• Stretta Therapy
• Bravo Reflux Testing System
• Digitapper Reflux Testing System

By Region:

• North America
• Latin America
• Europe
• Middle East & Africa
• Asia Pacific

- Of all regions globally, North America held the largest share of the Gastroesophageal Reflux Disease Device Market in previous years.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market players, including Medari Theraputics Inc., Takeda Pharmaceuticals Co. Ltd., Johnson & Johnson Services Inc., Olympus Corporation, Diversatek, Inc and others are looking forward to strengthening their market position.

View Full Report - https://www.marknteladvisors.com/research-library/global-gastroesophageal-reflux-disease-device-market.html